# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-286253
Filing Date
2022-11-16
Accepted
2022-11-16 07:24:59
Documents
20
Period of Report
2022-11-16

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | d422947d6k.htm | 6-K | 10012
2 | EX-99.1 | d422947dex991.htm | EX-99.1 | 3739
3 | EX-99.2 | d422947dex992.htm | EX-99.2 | 9624
4 | EX-99.3 | d422947dex993.htm | EX-99.3 | 19648
5 | GRAPHIC | g422947dsp3b.jpg | GRAPHIC | 11079
6 | GRAPHIC | g422947ex99_3p10g1.jpg | GRAPHIC | 250111
7 | GRAPHIC | g422947ex99_3p11g1.jpg | GRAPHIC | 221282
8 | GRAPHIC | g422947ex99_3p12g1.jpg | GRAPHIC | 210905
9 | GRAPHIC | g422947ex99_3p13g1.jpg | GRAPHIC | 326086
10 | GRAPHIC | g422947ex99_3p14g1.jpg | GRAPHIC | 233959
11 | GRAPHIC | g422947ex99_3p15g1.jpg | GRAPHIC | 80366
12 | GRAPHIC | g422947ex99_3p1g1.jpg | GRAPHIC | 165325
13 | GRAPHIC | g422947ex99_3p2g1.jpg | GRAPHIC | 456349
14 | GRAPHIC | g422947ex99_3p3g1.jpg | GRAPHIC | 208919
15 | GRAPHIC | g422947ex99_3p4g1.jpg | GRAPHIC | 410718
16 | GRAPHIC | g422947ex99_3p5g1.jpg | GRAPHIC | 300695
17 | GRAPHIC | g422947ex99_3p6g1.jpg | GRAPHIC | 351301
18 | GRAPHIC | g422947ex99_3p7g1.jpg | GRAPHIC | 247877
19 | GRAPHIC | g422947ex99_3p8g1.jpg | GRAPHIC | 284277
20 | GRAPHIC | g422947ex99_3p9g1.jpg | GRAPHIC | 301271
| Complete submission text file | 0001193125-22-286253.txt |  | 5638264

Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 221392942
SIC: 2834 Pharmaceutical Preparations